- Our Doctors
- Dr Jennifer Lim
Dr Jennifer Lim
MBBS, MPH, FRACP, AFRACMA, Medical Oncologist
I am a dedicated and empathetic clinician, deeply committed to delivering the highest standard of care to my patients. It is a privilege to support individuals and their families during some of their most difficult moments.
Languages spoken
English
Overview
Centres
Clinical interests
Clinical interests include Neuroendocrine tumours, GU cancers and translational research.
Dr Jennifer Lim is a medical oncologist with permanent clinical appointments at St George Public Hospital and Sutherland Hospital, and a Visiting Medical Officer at St George Private Hospital and Genesis Care Waratah Private.
She completed her MBBS at the University of New South Wales in 2011 and her basic physician training at the Royal Prince Alfred Hospital network.
Her oncology advanced training was based at the Chris O'Brien Lifehouse and Concord Hospital, with a clinical fellowship at The Kinghorn Cancer Care Centre. Dr Lim is completing her PhD at the Garvan Institute of Medical Research in translational biomarkers.
She is the clinical lead of the St George Interdisciplinary Neuroendocrine Group and a member of the head and neck and genitourinary multidisciplinary teams.
Professional memberships
- The Royal Australasian College of Physicians (RACP)
- Medical Oncology Group of Australia (MOGA)
- European Society for Medical Oncology (ESMO)
- American Society of Clinical Oncology (ASCO)
- Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)
- European Neuroendocrine Tumor Society (ENETS)
Publications
Loree, J. M., Chan, D., Lim, J., Stuart, H., Fidelman, N., Koea, J., ... & Singh, S. (2024). Biomarkers to Inform Prognosis and Treatment for Unresectable or Metastatic GEP-NENs. JAMA oncology, 10(12), 1707-1720. doi:10.1001/jamaoncol.2024.4330
Lim, J., Chin, V., Fairfax, K., Moutinho, C., Suan, D., Ji, H., & Powell, J. E. (2023). Transitioning single-cell genomics into the clinic. Nature Reviews Genetics, 24(8), 573-584. doi:10.1001/jamaoncol.2024.4330
Lim, J., Murphy, A., Wong, S., Nagrial, A., Karikios, D., Daneshvar, D., ... & Chin, V. (2022). Activin-A, Growth Differentiation Factor-11 and Transforming Growth Factor-β as predictive biomarkers for platinum chemotherapy in advanced non-small cell lung cancer. Cancer Treatment and Research Communications, 32, 100576.
Lim, J., Akbar Ali, A., Sim, H. & Prawira, A. (2022). Impact of Travel Distance on Clinical Trials Patients – the Kinghorn Cancer Centre (TKCC) Experience. Internal Medicine Journal, August 2022.
Lim, J., Lomax, A. J., McNeil, C., & Harrisberg, B. (2018). Uveitis and papillitis in the setting of dabrafenib and trametinib therapy for metastatic melanoma: a case report. Ocular Immunology and Inflammation, 26(4), 628-631.
Disclaimer:
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.